![Irvin Choo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Irvin Choo
Analyste en capital-investissement chez
DW Healthcare Partners (Canada)
Profil
Irvin Choo is currently working as a Vice President at DW Healthcare Partners (Canada).
He started this position in 2022.
Prior to this, he obtained an MBA from The University of Waterloo in 2019.
Postes actifs de Irvin Choo
| Sociétés | Poste | Début |
|---|---|---|
DW Healthcare Partners (Canada)
 DW Healthcare Partners (Canada) Investment ManagersFinance DW Healthcare Partners invests exclusively in healthcare companies. The firm's deal origination team develops and maintains relationships with thousands of business owners and identifies hundreds of potential investment opportunities annually. They actively pursue add-on acquisition opportunities for their partners which have proven to be an edge on growth in every competitive market. They target North American companies with EBITDA of $4 million or more and strong historical growth rates. DW Healthcare prefers to take majority ownership but may consider minority positions. Equity investments range from $15 million to $40 million. | Analyste en capital-investissement | 01/07/2019 |
Formation de Irvin Choo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DW Healthcare Partners (Canada)
DW Healthcare Partners (Canada) Investment ManagersFinance DW Healthcare Partners invests exclusively in healthcare companies. The firm's deal origination team develops and maintains relationships with thousands of business owners and identifies hundreds of potential investment opportunities annually. They actively pursue add-on acquisition opportunities for their partners which have proven to be an edge on growth in every competitive market. They target North American companies with EBITDA of $4 million or more and strong historical growth rates. DW Healthcare prefers to take majority ownership but may consider minority positions. Equity investments range from $15 million to $40 million. | Finance |
